Correlation Between Eliem Therapeutics and AbbVie
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and AbbVie Inc, you can compare the effects of market volatilities on Eliem Therapeutics and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and AbbVie.
Diversification Opportunities for Eliem Therapeutics and AbbVie
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and AbbVie is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and AbbVie go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and AbbVie
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the AbbVie. In addition to that, Eliem Therapeutics is 1.45 times more volatile than AbbVie Inc. It trades about -0.25 of its total potential returns per unit of risk. AbbVie Inc is currently generating about -0.03 per unit of volatility. If you would invest 18,945 in AbbVie Inc on August 30, 2024 and sell it today you would lose (637.00) from holding AbbVie Inc or give up 3.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Eliem Therapeutics vs. AbbVie Inc
Performance |
| Timeline |
| Eliem Therapeutics |
| AbbVie Inc |
Eliem Therapeutics and AbbVie Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and AbbVie
The main advantage of trading using opposite Eliem Therapeutics and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |